Synthon Biopharmaceuticals Reports Positive Early Results With Its Second Generation
 

Best-in-Class potential with improved therapeutic index compared to other armed antibodies Synthon Biopharmaceuticals, a subsidiary of specialty pharma company Synthon, has reported promising results with its lead program of antibody-drug conjugates (ADCs)...

More...